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Introduction
Head and neck squamous cell carcinoma (HNSCC) develops in the mucosal linings of the upper aerodigestive tract and contributes to approximately 5% of all cancers in the Western world (1, 2) . Well-known risk factors are tobacco smoking, excessive consumption of alcohol containing beverages, and infection with the human papillomavirus (HPV) (3) (4) (5) .
About one third of the patients present with early stage tumors and receive single modality treatment, either surgery or radiotherapy. The five-year-survival rates for patients with early disease stages are over 90%. Unfortunately the majority of HNSCC patients present with advanced disease stages. These patients are treated with either a combination of surgery and radiotherapy or chemoradiation, the concurrent application of systemic cisplatin chemotherapy combined with locoregional radiotherapy. Patients with advanced disease stage frequently develop locoregional recurrences, distant metastasis and/or second primary tumors, which results in five-year-survival rates of less than 60% (1) . Therefore, the development of novel anti-cancer agents to improve outcome is urgently awaited.
MicroRNAs (miRNAs) are ~22 nucleotide long, non-coding RNAs that are able to regulate the expression of multiple target genes (6) . Classically, miRNAs regulate the expression of target genes through sequence-specific complementarity between the miRNA seed sequence and the 3' untranslated region (UTR) of the target mRNAs (7) .
Perfect complementarity between the miRNA and the mRNA will generally target the mRNA for degradation, while imperfect complementarity of the miRNA to the 3'UTR will preferentially repress mRNA translation (8) . However, insights on the interaction of miRNA with their target genes evolve continuously. Through this regulation at the posttranscriptional level, miRNAs are able to modulate the expression of numerous genes simultaneously, thereby regulating individual signaling pathways at multiple levels (9) .
Several studies have shown the importance of miRNAs in cancer, including HNSCC.
Altered miRNA expression profiles have been observed in both HNSCC cell lines and tumors when compared to the normal counterpart tissues (10, 11) . The overexpression of has also been associated with increased expression in preneoplastic lesions during malignant progression (10) . A number of differentially expressed miRNAs were shown to be associated with poor prognosis, such as miR-21 and miR-211 (12, 13) . Even more interestingly, recent studies have revealed that miRNAs may act as tumor suppressors by targeting oncogenes. For example, the miR-16 family inhibits cell cycle progression and induces apoptosis via the silencing of BCL2 (14) , described in multiple tumor types including HNSCC. In a similar manner, ectopic expression of miR-181a resulted in decreased proliferation by targeting the oncogene KRAS (15) .
In the present study we examined the potential of miRNAs for treatment of HNSCC.
We hypothesized that miRNAs might cause tumor-specific cell death in HNSCC by targeting genes that might show a synthetic lethal interaction with one or more inactivated cancer genes. Several tumor-suppressing routes are inactivated in HNSCC amongst which the p53 and pRb pathways. Other genes or signaling routes may take over part of the lost functions and show a synthetic lethal interaction when inhibited (16) . We used a human miRNA expression library in retroviral vectors to perform a functional genetic screen to specifically identify miRNAs that cause cell death of tumor cells and not of primary keratinocytes. We further investigated, by expression array analysis, the target genes of these miRNAs as functional inhibition of the target genes may elicit the same lethal phenotype, and could be performed by small molecules.
Research. 
Material and Methods

Cell culture
Normal oral or oropharyngeal keratinocytes were isolated and cultured as previously described (17) . Conditionally immortalized oropharyngeal keratinocytes (ciOKC) were generated by transformation of primary oropharyngeal keratinocytes with a temperature-sensitive SV40 large T-antigen. CiOKC were cultured in Keratinocyte Serum Free Medium (KSFM; Invitrogen, Breda, The Netherlands) supplemented with 0.1% bovine serum albumin, 25 mg bovine pituitary extract, 2.5 µg human recombinant EGF, 250 µg Amphotericin B (MP biomedicals, San Francisco, United States of America) and 250 µg gentamycin (Sigma-Aldrich, Zwijndrecht, The Netherlands) at 32°C (18) . VU-SCC-120, VU-SCC-OE, UM-SCC-6, SiHa, MCF7, HT29, U87 and Phoenix cells were cultured in DMEM, 5% FCS, 2 mM L-glutamine, 50 U/ml Penicillin and 50 μg/ml Streptomycin at 37°C and 5%
CO2. The HNSCC cell lines used were all negative for the human papillomavirus and were sequenced for TP53 mutations. Cell line UM-SCC-6 was TP53 wild type, VU-SCC-120 contained two missense mutations (c.181_182CG>TT and c.527G>A) and VU-SCC-OE a truncating deletion (c.11_919del). Cell lines are authenticated regularly by their morphological characteristics and analysis of TP53 mutations and genetic markers.
Functional screen of human miRNA library
Amphotropic retroviral supernatants were produced for 370 annotated and putative miRNAs included in the human miRNA expression library (miR-Lib) with miR-Vec-Ctrl (scrambled sequence) as negative control (18, 19) . The conditionally immortalized oropharyngeal keratinocytes were used for screening experiments as described previously (18) . Both ciOKC and VU-SCC-120 cells (HNSCC cell line previously described as 93VU120 (20) ) were transduced at two following days for four hours in the presence of 3 µg/ml polybrene (Sigma-Aldrich, Zwijndrecht, The Netherlands). After 48 hours the cells were subjected to blasticidin selection. For ciOKC this was two days 4 µg/ml and subsequently 5 days of 8 µg/ml blasticidin (Sigma-Aldrich). For VU-SCC-120 the selection was performed with 10 µg/ml for seven days. For the initial screen, cell survival was assessed by visual inspection when the negative control (miR-Vec-Ctrl) had reached 100% confluency, and expressed as estimated percentage of the control (Supplementary Information). For subsequent validation experiments cell viability was quantified using the CellTiter-Blue® cell viability assay (Promega, Leiden, The Netherlands). The conversion of resazurin to resorufin was measured using the Infinite 200 plate reader (Tecan Group Ltd, Männedorf, Switzerland).
RNA isolation from FFPE tissue
Normal oropharyngeal mucosa was derived from three formalin-fixed paraffinembedded (FFPE) specimens from patients who underwent uvulopalatopharyngoplasty. In addition, FFPE tumor biopsies were obtained from five HNSCC patients. The mucosal epithelium was microdissected from sections of the uvula specimen as previously described (21) . Likewise, neoplastic areas were microdissected from tumor samples.
Microdissected tissues were treated with 1 mg/ml of proteinase K for 17 hours at 56°C in buffer containing 100 mM TRIS-HCl (pH 9.0), 10 mM NaCl, 1% sodium dodecyl sulphate (SDS) and 5 mM EDTA (pH 8.2). Nucleic acids were isolated by phenol-chloroform extraction and precipitated by sodium acetate and ethanol according to standard protocols using glycogen as carrier. After the nucleic acids were washed with 70% ethanol, they were redissolved in RNAse-free water.
Lentiviral shRNA ATM transduction
Lentiviral vectors with short-hairpin RNA sequences targeting ATM transcripts were obtained from the MISSION® short-hairpin library of The RNAi Consortium (Sigma-Aldrich, Zwijndrecht, the Netherlands) that is available at VU University Medical Center. Viral supernatants were produced by co-transfection of HEK239T cells using FuGENE® 6 Research. (Roche diagnostics, Woerden, The Netherlands) with the pLKO.1 short-hairpin vector together with the packaging and envelop vectors. Both ciOKC and VU-SCC-120 (HNSCC cell line) were transduced with lentiviruses at two following days for four hours in the presence of 3 µg/ml polybrene (Sigma-Aldrich). In total 48 hours after transduction cells were subjected to puromycin selection. For ciOKC this was two days 5 µg/ml and subsequently 5 days of 10 µg/ml puromycin (Sigma-Aldrich), and for VU-SCC-120 the selection was performed with 1 µg/ml for seven days.
Quantitative Reverse Transcription-PCR
Total RNA was isolated using the mirVana™ miRNA isolation kit (Ambion, Nieuwerkerk aan den IJssel, The Netherlands) according to the instructions of the manufacturer with the only modification that columns were eluted with 2x 25 µl elution buffer. Expression of hsa-miR-181a, hsa-miR-323, hsa-miR-326, hsa-miR-342, hsa-miR-345 and hsa-miR-371 was analyzed by Taqman® microRNA assays following the instructions of the manufacturer (Applied Biosystems, Nieuwerkerk aan den IJssel, The Netherlands). ATM expression was analyzed by Taqman® gene expression assay.
Relative expression was calculated via the comparative CT method using the small nucleolar RNA transcript RNU44 (for microRNA analysis) or beta-glucuronidase, (BGUS:
for ATM analysis) as internal references (22) . Quantitative RT-PCR reactions without reverse transcriptase were carried out in parallel for each RNA sample to exclude signal by contaminating genomic DNA.
Gene expression profiling
The retroviral clones with miRNA genes miR-181a, miR-323, miR-326, miR-342, miR-345 and miR-371 and negative control miR-Vec-Ctrl were transiently transfected in VU-SCC-120 by FuGENE® 6 (Roche diagnostics). Total RNA was isolated 72 hours after transfection using the mirVana™ miRNA isolation kit (Ambion). Microarray hybridization The log fold-changes between the reference group and each treated group were used to cluster the six treatments. This was carried out by means of hierarchical clustering with ward linkage, and the similarity defined both as the euclidean distance and as one minus the absolute value of the Spearman rank correlation measure. The grouping from 
ATM inhibitor treatment
Both ciOKC and VU-SCC-120 cells were subjected to a concentration range of 40 -0.075 μM ATM inhibitor CP466722 (Axon Medchem, Groningen, The Netherlands). After 72 hours, cell viability was assessed with the CellTiter-Blue® cell viability assay. 
Results
Identification of miRNAs lethal for HNSCC
To identify miRNAs that are lethal for head and neck cancer cells, we introduced a human miRNA expression library (miR-Lib) in HNSCC cell line VU-SCC-120 and close to normal conditionally immortalized primary oropharyngeal keratinocytes (ciOKC) ( Figure 1A ).
The ciOKC cells have been immortalized by a temperature-sensitive SV40 large T antigen.
When cultured at 32°C they are immortalized, while they become senescent when shifted to 39°C as a result of the inactivation of the large T-antigen. They behave, also at 32°C, as normal keratinocytes except for the immortalized phenotype (18) .
The majority of miRNAs did not influence the survival of either tumor cells or ciOKC cells, or the lethal effect was similar in both models. However, a subset of 19 miRNAs (5.4%) specifically affected the head and neck cancer cell line, whereas the ciOKCs remained unaffected (Supplementary Table S1 , Figure 1B) . To verify the tumor-specific lethal effect of these miRNAs, we screened all nineteen miRNAs in two different ciOKC cell clones and three HNSCC cell lines (VU-SCC-OE, UM-SCC-6 and VU-SCC-120). We could not confirm the tumor-specific lethal effect of thirteen miRNAs. The remaining six miRNAs showed the expected phenotype (Supplementary Figure S1) : a decreased proliferation in HNSCC cells but not in ciOKC cells and these miRNAs were further investigated. Visual inspection indicated that the tumor cells had disappeared from the wells indicating that they likely ceased proliferation and died. As yet, we did not elucidate the precise molecular mechanism behind the cell death.
For the initial large scale discovery screens we had to rely on the ciOKC cell model to study the effect of the miRNAs. In the subsequent small scale validation experiments we included primary keratinocytes. The miRNAs miR-181a, miR-323, miR-326, miR-342, miR-345 and miR-371 all showed a significant decrease in cell proliferation in three HNSCC cell lines, and not or only to a limited extent in primary keratinocytes ( Figure 1C ). The sequence identity of these six miRNAs was confirmed by Sanger sequencing (data not shown). 
MiRNA expression in HNSCC
Since the ectopic expression of the six tumor-selective lethal miRNAs caused cell death in tumor cell lines but not or less in mucosal keratinocytes, we were interested in the expression of these miRNAs in HNSCC tumors and normal oral mucosa. Hence we determined expression levels for the six miRNAs in RNA extracted from both microdissected tumor and mucosal epithelium. MiR-371 was not expressed, neither in normal mucosa nor in the five tumors analyzed (data not shown). For the other five miRNAs expression was observed in all tumor and mucosal epithelium samples, but apparently at a low level (Figure 2 ). The expression levels of the miRNAs were in all cases lower than the expression of the RNU44 reference gene. In addition, only small differences in expression levels were observed between mucosa and tumor samples. The expression of miR-181a was slightly increased in tumors, but not significant (Figure 2A ). For miR-326, miR-342 and miR-345 the expression level in tumor tissue was decreased when compared to normal mucosal epithelium, but not significantly. Only the expression level of miR-323 was significantly lower in tumor cells ( Figure 2B ).
Tumor-specific lethal phenotype in cell lines of different cancer types
We next questioned whether the effect observed in the HNSCC cell lines was specific for HNSCC. Therefore we tested the six miRNAs with HNSCC-specific lethal effects in other cancer cell lines. The introduction of the various miRNAs in cervical carcinoma cell line (SiHa) and breast carcinoma cell line (MCF7) had no effect on 
status of specific cancer genes or deregulated signaling pathways in the various cell lines of different tissue origin, and it might be worthwhile to repeat these functional screens for other tumor types as it might reveal other candidate microRNAs. The lethal interaction is likely not related to a mutation in TP53 as all miRNAs showed the tumor-selective lethal effect in all three HNSCC cell lines while one cell line was TP53 wild type, one showed two missense mutations and one a large deletion (see Material and Methods for details).
Target gene analysis
MiRNAs regulate gene expression at the post-transcriptional level, so we were interested in the downstream gene targets of these six tumor-specific lethal miRNAs that might explain the cell growth inhibitory phenotype. First we performed an in silico analysis.
There is a multitude of software tools available for target identification [reviewed in (24) ], and we chose TargetScan and DIANA-microT. We also defined the overlap between genes detected by the two programs (Supplementary Table 4 ). There was a wide variety of potential genes identified with over 700 for miR-181a. This analysis did not give a direct clue.
Therefore we performed micro-array based gene expression analysis to identify candidate target genes. Since ectopic expression of these miRNAs caused a decrease in cell proliferation and cell death as phenotype in HNSCC cell lines, we were unable to analyze cells stably transduced with the miRNAs. We therefore decided to transiently transfect VU-SCC-120 cells with the retroviral vector plasmids instead of transduction with retroviral particles. Transient transfection is efficient, and overexpression can be observed almost immediately. RNA was isolated 72 hours post-transfection, the time point with high miRNA expression, but before cell death was observed (Supplementary Fig. S3 ). The expression level of the transfected miRNAs was also determined. Depending on the endogenous expression of the miRNAs in VU-SCC-120 cells, expression increased from 23 to 4,000 fold after transient transfection ( Figure 3A and 3B) . 
Next, total RNA of the transfected cells was labeled and hybridized for gene expression profiling by micoarray hybridization. We assumed that some of these six miRNAs might in fact target the same genes, and we therefore focused on a group-wise comparison. In the expression profiles we indeed observed significant correlations between miRNA associated mRNA expression profiles (Table 1) . Highly significant correlations were observed for miR-181a and miR-326 (r=0.572), miR-326 and miR-345 (r=0.573), miR-323 and miR-371 (r=0.602) and miR-342 and miR-323 (r=0.577). Cluster analysis revealed two groups of each three miRNAs with downstream target effects that showed significant correlations ( Figure 3C ; Supplementary Tables S2 and S3 ). MiRNAs miR-181a, miR-326 and miR-345 clustered together in group A and group B was composed of miR-342, miR-371 and miR-323. The profiles of the miRNAs per group were combined and analyzed against the empty vector control (in tetraplicate hybridized on the arrays) to detect significant differentially expressed genes.
In total we observed 187 and 15 genes (FDR corrected p-value < 0.1) that were significantly differentially expressed genes in group A and B, respectively, as compared to the empty vector control. Subsequently, we applied several rankings on the differentially expressed genes to distinguish primary effects from secondary effects. First, we ranked the genes for a decreased level of expression, as miRNAs are considered to cause downregulation of expression of their target genes. Second, as for many genes multiple probes were present on the array, we subsequently ranked the genes for the number of probes per gene detected with an FDR corrected p-value <0.1 (Supplementary Tables S2   and S3 ). One of the most striking target genes that is apparently regulated by the miRNAs from group A is the ataxia telangiectasia mutated (ATM) gene. First the differences of many probes are highly significant given the limited sample size (four controls versus three miRNAs of group A analyzed in duplicate) and the conservative p-value adjustment.
Second, in total 9 of 12 ATM probes were significantly regulated. Unfortunately, we did not find such an apparent lead target for the miRNAs in group B. 
Knockdown of ATM causes tumor-specific lethality
ATM is a nuclear protein kinase that senses DNA damage and activated downstream pathways (24) . To validate the observed decrease in expression we performed qRT-PCR for ATM in the same samples that were transiently transfected with the miRNAs and that were analyzed by micro-array hybridization. Indeed we confirmed that ATM expression is inhibited in the RNA samples from group A ( Figure 4A ).
Since ectopic expression of miR-181a, miR-326 and miR-345 results in tumorspecific lethality and down-regulation of ATM expression, we hypothesized that knockdown of ATM may also be accompanied by tumor-specific lethality in HNSCC cells. Therefore we introduced five lentiviral shRNA constructs designed to specifically knockdown ATM ATM is a kinase and druggable by kinase inhibitors. To confirm the tumor-specific decrease in cell viability by ATM inhibition, we also subjected ciOKC and HNSCC cells to different concentrations of the commercially available specific ATM inhibitor CP466722.
Analysis of cell viability shows that HNSCC cells are more sensitive to the inhibitor compared to the ciOKC cells ( Figure 4D ). The IC50 of 8.2 μM in ciOKC cells shifts to 2.6 μM in VU-SCC-120, a significant change of 3 fold (p-value <0.05 by T-testing). Fig. S4 ). Next miRNAs, miR-181a, miR-326 and miR-345 were introduced in these two cell lines and compared to untransduced VU-SCC-120 (ctrl). The miRNAs all showed a decrease in cell proliferation in the untransduced VU-SCC-120 ( Figure 4F ). However, in the cells with the ATMwt expression construct, cell proliferation was rescued up to ~80% (miR181a) and ~50% (miR-326 and miR-345). Rescue was not observed when the kinase-dead mutant ATM was ectopically expressed in VU-SCC-120 cells. These data indicate that the miRNAs inhibit ATM expression, which elicits the tumor-selective lethal phenotype and it depends on the kinase activity of ATM.
Targeting of ATM by miR-181a, -326-and -345
MiRNAs are known to regulate gene expression post-transcriptionally via binding to the 3'UTR or coding sequences of an mRNA sequence. To demonstrate an effect of miR181a, miR-326 and miR-345 on the 3'UTR of the ATM gene miRNAs were cotransfected with a luciferase reporter construct cloned to the ATM 3'UTR sequence. Transfection of ciOKCs with miR-181a and miR-326 suppressed the activity of a luciferase reporter gene cloned to the 3′UTR of ATM. MiR-345 did show an effect, but not significant (Fig. 4E) .
The knockdown of ATM by the respective microRNAs seems to inversely correlate with the effect of ectopic ATM expression This suggests that some miRNAs might not target the 3'UTR, but the 5'UTR or coding sequences. These sequences are still present in the expression construct, only the 3'UTR of ATM has been substituted. In addition, ectopic ATM expression does not rescue the lethal phenotype to 100%, and we hypothesized that another gene target might be involved as well. First, we re-inspected our expression data and found another gene significantly down-regulated in 9 of 10 available probes: CD40. We next checked the presence of microRNA target sites using RNA22 and TargetScan on both ATM and CD40. Multiple binding sites were found for these microRNAs in these genes, albeit mostly not in the 3'UTR region (Supplementary Fig. 5 ). The relevance of the various putative miRNA target sites, and the role of CD40 and its interaction with ATM requires further elucidation. 
Discussion
In the present study we identified six miRNAs that, when ectopically expressed, lead to a tumor-specific inhibition of proliferation in HNSCC cells and not in primary keratinocytes. MiRNAs are generally classified into different families based on their sequence homology, most particularly of the seed sequence, and it is hypothesized that different miRNAs within the same family may have similar effects on gene expression.
Although all miRNAs highlighted in this study have a tumor-specific lethal effect, and some even recognize at least one identical and apparently critical target gene, they do not belong to the same family.
Many miRNAs have already been implicated in cancer development and progression. For miR-345 a role in head and neck cancer development has been suggested previously by profiling studies. In these studies miRNA expression profiles in tumor samples were compared to normal mucosal epithelium, and it was shown that miR-345 showed an increased expression level in malignant cells (10) .
MiR-181a has been shown by functional studies to have tumor-suppressive properties in HNSCC (15) . Here we show a tumor-specific lethal effect for ectopic expression of these two miRs as well as miR-326, miR-342, miR-371 and miR-323 in head and neck cancer cells. We also show that a similar lethal effect was observed when those six miRNAs were introduced in colon cancer and glioblastoma cell lines, although there was a considerable variation in the lethal phenotype between cell lines of different origin. It might therefore be of interest to repeat similar screens in other tumor types. Unfortunately it is not always possible to have access to matched normal (or near normal) cells, which are required to allow a tumor-specific lethal screen and subsequent validation. Assuming that the identified hits are synthetic lethal with cancer-associated alterations in conserved cellular pathways such as cell cycle control or DNA repair, the precise source and histotype of the normal reference cells might be less critical, and normal fibroblasts may be sufficient. 
be regulated by multiple miRNAs, but also one miRNA may regulate multiple genes.
Consequently, it is difficult to study downstream targets of a particular miRNA particularly as the target genes may also be involved in the regulation of expression of other genes.
Therefore it is not surprising that many genes were shown to be significantly differentially expressed when the effect of the six tumor-specific lethal miRNAs was analyzed. Although the expression profiles of the six miRNAs were not similar, it was interesting to observe that two groups could be discriminated. Unfortunately, we could not identify an apparent candidate target gene in group B. Likely multiple repeats of the array analysis in multiple cell lines will be required to define more convincing candidate target genes. The limited sample size combined with the strict FDR correction of the p-values may have skewed the analyses. Moreover, miRNAs might also influence genes at the translational level, which would necessitate alternative approaches to identify the candidate target genes.
However, in group A several probes for ataxia telangiectasia mutated (ATM) showed significant differences. Using ATM 3'UTR luciferase reporter experiments we demonstrated that both miR-181a and miR-326 seem to directly target the 3'UTR sequence of ATM. We could not confirm this for miR-345. We also showed that specific downregulation of ATM via shRNA knockdown elicits a similar tumor-specific lethal phenotype.
Although there was a slight toxic effect in the normal squamous epithelial cells, the lethal phenotype observed in HNSCC cell lines was much more severe, and HNSCC cells are more sensitive to the specific ATM inhibitor CP466722. Finally, the tumor-selective phenotype of the miRNAs could be rescued by introduction of an ATM expression construct that lacks the 3'UTR of ATM itself, while the phenotype could not be rescued by expression of a kinase-dead mutant. more in the coding cDNA sequence. Mutation of predicted target sites will be required to proof the relevance of all of them, which will be a major future task. A worrying observation is that the various prediction programs come up with different potential binding sites, hampering a focused approach. Nonetheless such experiments will be required to establish the ultimate proof of ATM targeting by these microRNAs of group A.
We also observed that the rescue level never reaches 100% cell survival. There might be many explanations for this observation, but it suggests that also another target gene might be involved, and we could pinpoint CD40 as a first hint. Additional experiments will be required to proof this, and that combined targeted treatment might be of benefit.
Our data thusfar suggests that HNSCC cells are depending on ATM signaling for their survival. When ATM expression is lost, either by shRNA knockdown or when targeted by a miRNA, the cell is unable to survive, at least under culture conditions. ATM senses DNA damage and phosphorylates CHEK2 which in turn activates p53 by phosphorylation.
This route plays a major role in maintaining genome integrity and cell cycle control (25) .
Intriguingly, TP53 is mutated in two of the three HNSCC cell lines tested and ATM may have become more critical to organize DNA repair or induce a cell cycle block during S/G2 phase after DNA damage independent of p53. The third cell line UM-SCC-6 is TP53 wild type but it is unclear whether p53 is still functionally active. Detailed analyses of the ATM/ATR-CHEK1/CHEK2 pathway should reveal which critical downstream signalling route causes the lethal phenotype, and what the mechanism is. Obviously ATM has many downstream targets, and the tumor-selective phenotype might be related to alterations in other signalling routes. Nonetheless, our data suggest that ATM is an interesting drug target for HNSCC.
Previously it has been shown that miR-181a targets KRAS, and this was put forward as explanation that this particular microRNA inhibits proliferation of squamous cancer cells (15) . This seemed a little remarkable as KRAS mutations are hardly found in HNSCC, suggesting that this is not the most critical driving gene or even pathway in 
